Intervention Review

Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration

  1. Usha Reddy1,*,
  2. Magdalena Krzystolik2

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 26 JUL 2007

DOI: 10.1002/14651858.CD005138.pub2

Database Title

Additional Information

How to Cite

Reddy U, Krzystolik M. Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005138. DOI: 10.1002/14651858.CD005138.pub2.

Author Information

  1. 1

    c/o Cochrane Eyes and Vision Group US Project, Baltimore, USA

  2. 2

    Southern New England Retina Associates, Providence, USA

*Usha Reddy, c/o Cochrane Eyes and Vision Group US Project, 615 North Wolfe Street, Mailbox Room W 5010, Baltimore, MD 21218, USA. ushareddy@aol.com.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (186K)Full (205K)

  1. Current Version

    Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration

    Usha Reddy and Magdalena Krzystolik

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD005138.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Interferon alfa therapy for age-related macular degeneration

    U Reddy and M Kryzstolik

    Article first published online: 19 OCT 2005 | DOI: 10.1002/14651858.CD005138

View Full Article (HTML) Summary (57K)Standard (186K)Full (205K)